​

Funding Round

Post-IPO Equity - F-Star Therapeutics

Post-IPO Equity - F-Star Therapeutics

Investment Firm

Overview

F-Star Therapeutics is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

Announced Date

Nov 20, 2020

Funding Type

Post Ipo Equity

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorM Ventures
Participant InvestorSR One
Participant InvestorAescap Venture
Participant InvestorAtlas Venture

Round Details and Background

F-Star Therapeutics raised $15000000 on 2020-11-20 in Post-IPO Equity

F-Star Therapeutics is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2007
Seed Round - F-Star Therapeutics
1-2.0M
Nov 28, 2007
Series A - F-Star Therapeutics
1-4.4M
Sep 10, 2007
Series A - F-Star Therapeutics
2-8.3M
Jan 06, 2010
Series A - F-Star Therapeutics
6-11.5M

Recent Activity

There is no recent news or activity for this profile.